I can understand your logic here Thwhack, but my understanding of the situation is:
1. While ACL can see members in the trial with long (even very long PFS), and they can see a proportion with standard PFS they will not know the results until the blindfolds are removed. Until that point the distribution of PFS to treatments is conjecture.
2, Here we have a firm run by scientists who know how the science game is played. Accoording to the rules!
One could argue that, if they conject in any way that the results are outstanding, that will be seen as improper, because officially (and scientifically) they do not know.
Glad you got your 50% I'm still waiting for mine.
- Forums
- ASX - By Stock
- TSN
- Observations that make me uncomfortable
TSN
the sustainable nutrition group ltd
Add to My Watchlist
0.00%
!
1.0¢

Observations that make me uncomfortable, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online